Revance Therapeutics Market Cap

BOM:532181 has a market cap or net worth of 127.85 billion as of August 8, 2025. Its market cap has decreased by -2.20% in one year.

Market Cap

127.85B

Enterprise Value

123.29B

Revenue

27.65B

Ranking

n/a

PE Ratio

19.21

Stock Price

$396.15

Market Cap Chart

Since July 30, 1999, BOM:532181's market cap has increased from 10.67B to 127.85B, an increase of 1,098.36%. That is a compound annual growth rate of 10.01%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	127.85B	24.94%
Dec 31, 2024	102.33B	-20.93%
Dec 29, 2023	129.43B	177.53%
Dec 30, 2022	46.63B	98.58%
Dec 31, 2021	23.48B	40.40%
Dec 31, 2020	16.73B	-14.54%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	17.70T
HDFC Bank	15.24T
Bharti Airtel	11.57T
Tata Consultancy Services	10.97T
ICICI Bank	10.31T
State Bank of India	7,432.66B
Hindustan Unilever	5,957.62B
Infosys	5,955.37B

Market Cap Rankings